Diamonds and Dogs

5/22/23

Pfizer (PFE) jumps on drug data. Pfizer is up 4 %as their diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to data published in a medical journal. The weight-loss treatment market is estimated to reach $100 billion by the end of the decade.

Micron (MU) lower on news out of China. Micron Technology is down 3% as China's cyberspace regulator said that Micron's products failed to pass a cybersecurity review in the country. Beijing warned operators of key infrastructure against buying the company's goods. The e US Commerce Department said Beijing's conclusion had "no basis in fact" and was more of political move.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.